专科转诊中心采用肌肉骨骼感染学会结局报告工具报告两阶段翻修术治疗假体周围感染的成功率较低
该研究回顾性分析了一家专科转诊中心13年间67例计划性两阶段翻修治疗全髋关节置换术后假体周围感染的患者,平均随访8.6年。采用肌肉骨骼感染学会结局报告工具(MSIS ORT)标准,治疗成功率为58.2%,而采用Delphi标准则为86.6%,显示不同报告标准间存在差异。作者认为在专科转诊中心,两阶段翻修的成功率可能低于既往报告。
要点
- 采用MSIS ORT标准,67例中39例(58.2%)治疗成功,其中Tier 1为37例(55.2%),Tier 2为2例(3%)。
- 采用Delphi标准,治疗成功率为86.6%。
- 18例患者未进行再植入并保留间隔物(Tier 3F),3例(4.5%)在治疗期间死亡,20例(29.9%)接受慢性抗生素抑制治疗。
核心结论
- 本研究提示,在专科假体周围感染转诊中心,两阶段翻修的成功率可能低于既往报告,并凸显了不同报告标准间的差异。
- 随着假体周围感染治疗向专科中心集中,间隔物保留可能更为常见,治疗复杂病例时需要一致且透明的结局报告。
研究设计与样本
- 回顾性评估一家专科三级医院13年间连续接受计划性两阶段翻修治疗全髋关节置换术后假体周围感染的患者。
- 共纳入67例患者,平均随访8.6年(范围2.5至15.0年),最低随访2年,包括计划外保留间隔物的患者。
- 主要结局为采用Delphi标准和肌肉骨骼感染学会结局报告工具(Tier 1和Tier 2)定义的治疗成功,并记录再植入失败(Tier 3F)。
主要发现
- 采用MSIS ORT标准,治疗成功39例(58.2%),其中Tier 1为37例(55.2%),Tier 2为2例(3%)。
- 采用Delphi标准,治疗成功率为86.6%。
- 18例患者未进行再植入并保留间隔物(Tier 3F)。
- 3例(4.5%)在假体周围感染治疗期间死亡,20例(29.9%)接受慢性抗生素抑制治疗。
- 考虑伴或不伴再植入的感染控制,总体治疗成功57例(85.1%)。
关键数值与推荐
- 治疗成功定义采用Delphi标准和肌肉骨骼感染学会结局报告工具(Tier 1和Tier 2)。
- 再植入失败记录为Tier 3F。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The gold standard treatment for total hip arthroplasty (THA) periprosthetic joint infection (PJI) is a two-stage revision. Reported success rates are greater than 80%; however, significant differences remain in how treatment success rates are defined. The purpose of this study was to evaluate our specialized, tertiary hospital's experience with planned two-stage revisions for complex THA PJI. METHODS: Consecutive patients who underwent a planned two-stage revision for THA PJI at our institution over a 13-year period were assessed. Patients had a minimum 2-year follow-up, and those who had unplanned spacer retention were included. The primary outcome was treatment success defined by the Delphi Criteria and Musculoskeletal Infection Society Outcome Reporting Tool (Tiers 1 and 2). Failure for reimplantation (Tier 3F) was recorded. Baseline characteristics were collected. Factors associated with treatment outcome were analyzed. A total of 67 patients were identified at a mean follow-up of 8.6 years (range, 2.5 to 15.0). There were 16 patients who underwent previous surgeries for their PJI (23.9%). RESULTS: Utilizing the Musculoskeletal Infection Society Outcome Reporting Tool criteria, treatment success was achieved in 39 patients (58.2%) with reimplantation (Tier 1: 37 [55.2%], Tier 2: two [3%]). In contrast, an 86.6% success rate was noted when utilizing the Delphi criteria. Eighteen patients did not proceed with reimplantation and retained their spacers (Tier 3F). There were three patients (4.5%) who died during PJI treatment and 20 patients (29.9%) who were placed on chronic antibiotic suppression. Considering infection control with and without reimplantation, overall treatment success was achieved in 57 patients (85.1%). CONCLUSIONS: Our study suggests that two-stage revisions at specialized PJI referral centers may be less successful than previously reported and highlights discrepancies between reporting measures. As PJI care moves toward specialized PJI centers, where spacer retention may be more prevalent, there is a need for consistent and transparent reporting of outcomes when treating complex cases.
引用
- Tubin N, Bonello JP, Abdelbary H, et al. Lower Reported Success Rates of Two-Stage Revisions for Periprosthetic Joint Infections Using Musculoskeletal Infection Society Outcome Reporting Tool at a Specialty Referral Center. J Arthroplasty. 2025. PMID: 41106701. doi:10.1016/j.arth.2025.10.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。